Dr. Marat Fudim and Dr. C. Michael Gibson discuss: Outcomes of Intracoronary AAV1/SERCA2a Gene Therapy in Patients With Heart Failure With Preserved Ejection Fraction: 12-Month Results From the MUSIC-HFpEF Phase 1/2a Trial August 31, 2026 2026 | ESC | Slides | Trial | Video Fudim_ESC-CongressDownload Disclosures: TBD Article Navigation Dr. Steven Nissen and Dr. C. Michael Gibson discuss: Effect on Oxidized Phospholipids of Lepodisiran, an Extended Duration siRNA Targeting Lipoprotein(a) Dr. Keyur Vora and Dr. C. Michael Gibson discuss: Intravenous Dexrazoxane for Hemorrhagic Myocardial Infarction in STEMI: A Double-Blind, Placebo-Controlled, Sequential-Cohort Phase IIa Trial (SHIELD-MI)
